conducted a pan-cancer analysis of PSMB8, 9 and 10 expression and immune infiltration and found that PSMB8, 9 and 10 co-expression was linked to increased CD8 T cell, natural killer cell and activated dendritic cell gene signatures in most cancer types. This evidence concerns the gene CD8A and cancer.